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Abstract
Background: Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) phosphorylates and activates particular
downstream protein kinases — including CaMKI, CaMKIV, and AMPK— to stimulate multiple Ca2+-signal
transduction pathways. To identify previously unidentified CaMKK substrates, we used various nucleotides as
phosphate donors to develop and characterize an in vitro phosphorylation assay for CaMKK.
Results: Here, we found that the recombinant CaMKK isoforms were capable of utilizing Mg-GTP as a phosphate
donor to phosphorylate the Thr residue in the activation-loop of CaMKIα (Thr177) and of AMPK (Thr172) in vitro.
Kinetic analysis indicated that the Km values of CaMKK isoforms for GTP (400-500 μM) were significantly higher than
those for ATP (~15 μM), and a 2- to 4-fold decrease in Vmax was observed with GTP. We also confirmed that an ATP
competitive CaMKK inhibitor, STO-609, also competes with GTP to inhibit the activities of CaMKK isoforms. In
addition, to detect enhanced CaMKI phosphorylation in brain extracts with Mg-GTP and recombinant CaMKKs, we
found potential CaMKK substrates of ~45 kDa and ~35 kDa whose Ca2+/CaM-induced phosphorylation was
inhibited by STO-609.
Conclusions: These results indicated that screens that use STO-609 as a CaMKK inhibitor and Mg-GTP as a
CaMKK-dependent phosphate donor might be useful to identify previously unidentified downstream target
substrates of CaMKK.
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Background
Ca2+/calmodulin-dependent protein kinase kinase (CaMKK)
has been classified as a novel member of the calmodulin
kinase (CaMK) family that specifically phosphorylates a
single Thr residue (Thr177 or Thr196, respectively) within
the activation loop in each of two multifunctional cal-
modulin (CaM) kinases, CaMKI and CaMKIV; these phos-
phorylation events cause a large increase in catalytic
efficiency [1-3]. Accumulated biochemical evidence indi-
cates that CaMKK phosphorylates Akt/Protein kinase B [4]
and AMPK (AMP-activated protein kinase) family mem-
bers including the catalytic subunit of AMPK (AMPKα) at
Thr172 [5-8] and SAD-B (known as a brain-specific kinase,
BRSK1) at Thr189 [9]; either phosphorylation event causes
significant catalytic activation, and these findings indicate
that CaMKK confers Ca2+ dependence on other signalling
pathways. In mammals, two CaMKK genes (CaMKKα and
CaMKKβ) have been identified, and both are highly
expressed in the brain; the α isoform is also expressed in
various peripheral tissues such as thymus and spleen [10].
A CaMKK gene has been found in Caenorhabditis elegans
and in Aspergillus nidulans, and the proteins encoded by
these genes are components of the CaMK cascade within
the respective organisms [11,12]. Interestingly, both mam-
malian CaMKK isoforms bind to Ca2+/CaM as well as to
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CaMKI and CaMKIV proteins that function downstream
of Ca2+/CaM complexes [13,14]. Indeed, Ca2+/CaM bind-
ing is absolutely required for the relief of CaMKKα autoin-
hibition [15], which results in its activation like other
CaMKs. Previous structural and functional studies of
CaMKK have revealed a novel CaM-binding motif (1-16)
[16], and the unique feature of the CaM-binding segment
in CaMKK is required for the autoinhibitiory mechanism
through Ile441 in CaMKKα [15].
Many cell types depend on a functional CaM-kinase cas-
cade that leads to activation of CaMKI and CaMKIV in
response to Ca2+ mobilization. The CaMKK/CaMKIV cas-
cade has an important role in Ca2+-dependent regulation of
gene expression that is mediated by phosphorylation of
transcription factors such as cAMP-response element bind-
ing protein (CREB) [17]. Analysis of CaMKIV-deficient
mice revealed that the CaMKIV-mediated pathway plays an
important role in the development and function of the
cerebellum and is critical for both male and female fertility
[18,19]. The CaMKK/CaMKI cascade has been shown to
be involved in various neuronal functions, including spino-
genesis [20], dendritic arborization [21] and cortical axon
elongation [22]. Recent accumulated data have shown that
Ca2+-dependent phosphorylation and consequent activation
of AMPK is mediated by CaMKKβ when T-cells are acti-
vated via the antigen receptor [23] or when HeLa cells were
treated with a Ca2+ ionophore [24]. Based on these results,
CaMKK is predicted to act as a regulatory protein kinase in
various Ca2+-dependent cellular processes in vivo. There-
fore, identification of novel target(s) of CaMKK is import-
ant for the clarification of the CaMKK-mediated signaling
pathway. Here, we found and characterized an enzymatic
feature of CaMKK isoforms that might be useful in screens
for novel targets of CaMKK; specifically, these enzymes can
use GTP, as well as ATP, as a phosphate donor.
Results and discussion
CaMKK is capable of using Mg-GTP as a phosphate donor
In general, in vitro phosphate labeling of substrates in
crude tissue or cell lysates is an essential experimental
step in the identification of novel downstream targets
for protein kinases; nevertheless, it is technically difficult
to phosphorylate physiologically relevant substrates via
target protein kinases in crude tissue and cell extracts. If
ATP is used as a phosphate donor in phosphorylation
reaction that use crude tissue or cell extracts as the kin-
ase source, background phosphorylation by myriad en-
dogenous protein kinases is unavoidable since ATP is
utilized by every known protein kinase as a phosphate
donor. To identify novel substrates for CaMKK, we first
tested whether CaMKK can utilize other nucleotides as
substitutes for ATP in the phosphorylation reaction. To
examine the ability of recombinant CaMKKα isoform to
use non-ATP nucleotides in vitro (Figure 1A), we used 1
mM GTP, UTP, or CTP, as well as 1 mM ATP (the posi-
tive control), as the sole phosphate donor, CaMKK as
the kinase, and GST-CaMKIα (1-293, K49E; a kinase
dead mutant lacking the Ca2+/CaM-binding region) as
the substrate in Thr177 phosphorylation reactions; all
reactions included Mg2+. We used this CaMKI mutant
as a CaMKK substrate because it does not need to bind
Ca2+/CaM to be phosphorylated by CaMKK; addition-
ally, this mutant allows us to rule out any confounding
effects of CaMK-mediated feedback phosphorylation of
CaMKK [15]. Western blot analysis and an anti-phos-
phoThr177 monoclonal antibody were used to detect
site-specific phosphate incorporation into GST-CaMKIα
1-293, K49E. CaMKKα could use GTP, UTP, or the posi-
tive control (ATP) as a phosphate donor (Figure 1A);
however, phosphorylation with UTP was less efficiently
than that with GTP or ATP; phosphate incorporation
with UTP was ~50% of the maximum incorporation
observed within 10 min with ATP or GTP. Moreover,
CaMKKα was incapable of using CTP as a phosphate
donor. Next, we used GTP, as well as ATP, in vitro under
various conditions to confirm the kinase activity of re-
combinant CaMKKα (Figure 1B). The CaMKKα isoform
was capable of phosphorylating Thr177 in the CaMKI sub-
strate with GTP only in the presence of Mg2+ as well as
Mg-ATP. When we incubated the reaction mixture at 68°C
for 10 min before initiating the phosphorylation reaction,
no phosphate incorporation into Thr177 of the CaMKI mu-
tant was observed. This result indicated that this was an
enzyme-catalyzed reaction because conditions designed to
denature enzymes abolished the observed activity.
Isoform specificity of CaMKK for utilizing Mg-GTP
CaMKK is composed of either α or β isoforms [10,11] that
phosphorylate and activate AMPK as a native substrate in
addition to CaMKI. Next, we characterized the ability of
the CaMKK isoforms to phosphorylate these two down-
stream substrates with 1 mM ATP, GTP, or UTP in the
presence of 10 mM Mg(CH3COO)2 (Figure 2). Under the
conditions of our time course experiments examining
phosphorylation, both CaMKK isoforms were able to use
ATP or GTP to phosphorylate Thr177 in CaMKIα 1-293,
K49E, and the kinetics of the reactions were comparable
(Figure 2A). Consistent with the results of Figure 1A,
CaMKKα could utilize Mg-UTP, but with slower catalysis;
moreover, the β isoform was incapable of using UTP
under these experimental conditions. On the other hand,
only CaMKKβ was capable of phosphorylating the α sub-
unit of AMPK at Thr172 with Mg-GTP, while both
CaMKK isoforms could phosphorylate AMPK with Mg-
ATP (Figure 2B). This finding was consistent with the ob-
servation that the GST-fused catalytic domain of CaMKKβ
(residues 162-470), but not CaMKKα catalytic domain
(residues 126-434), phosphorylated AMPK with Mg-GTP
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(data not shown). Neither CaMKK isoforms could use
UTP or CTP to phosphorylate AMPK (data not shown).
These results indicated that CaMKK isoforms could use
Mg-GTP for target phosphorylation depending on down-
stream substrates.
Kinetic analysis of CaMKK isoforms
To further characterize the ability of CaMKK isoforms to
use GTP as a phosphate donor, we then compared the
kinetic parameters of CaMKK isoforms with ATP or GTP
as the phosphate donor and GST-CaMKIα 1-293, K49E as
the CaMKK substrate. The Km values of both CaMKK iso-
forms for GTP were ~30-fold higher (400~500 μM) than
those for ATP (~15 μM); however, a 2- to 4-fold decrease
in Vmax was observed with GTP for both CaMKK isoforms
under our experimental conditions (Table 1). The Vmax/Km
values of GTP for both CaMKK isoforms were two order
of magnitude lower than those of ATP (Table 1). Thus,
GTP is considered a less efficient substrate for CaMKKs
than ATP.
Inhibition of CaMKK activities using Mg-GTP by STO-609
Based on the enzymatic characterization of CaMKK iso-
forms with regard to the ability to utilize various nucleo-
tides as described above, Mg-GTP can be used for
phosphate-labeling of CaMKK substrates in crude tissue
extracts. However, a number of other protein kinases —
including casein kinase II, CaMKII and protein kinase
C — can use Mg-GTP as a phosphate donor [25-28].
Therefore, we need an additional selection method to
identify CaMKK-specific substrates that are phosphory-
lated by CaMKK isoforms using Mg-GTP. Previously, we
synthesized 7H-benzimidazo[2,1-a]benz[de]isoquinoline-
7-one-3-carboxylic acid (STO-609) as a CaMKK inhibitor
that has been shown to be an ATP-competitive compound
[29]. Next, we tested whether STO-609 was capable of
inhibiting the activity of each CaMKK isoform when 50
μM [γ-32P]GTP was used as a phosphate donor. CaMKKα
activity was inhibited by > 90% in presence of 1 μg/ml
STO-609, and CaMKKβ was inhibited by > 90% in pres-
ence of 0.1 μg/ml STO-609 (Figure 3A). CaMKKβ was ~7
times more sensitive to STO-609 than was CaMKKα
when Mg-GTP was used as the phosphate donor
(CaMKKα, IC50 = 80 ng/ml; CaMKKβ, IC50 = 12 ng/ml);
this inhibitory profile was similar to that with 50 μM Mg-
ATP (CaMKKα, IC50 = 120 ng/ml; CaMKKβ, IC50 = 40
ng/ml) as the phosphate donor [29]. Kinetic analysis of the
inhibition of CaMKK isoforms by STO-609 (Figure 3B)
showed the degree of inhibition observed with varying
concentrations of GTP (100 – 400 μM) in the presence or
absence of STO-609 (0.1 μg/ml) for CaMKKα (Figure 3B
left panel) and in the presence or absence of STO-609
(0.01 μg/ml) for CaMKKβ (Figure 3B right panel). As
there was no change in the Vmax value for the two CaMKK
isoforms, the apparent Km value for GTP increased with
increasing concentrations of STO-609, indicating that the
inhibition was competitive with respect to GTP.
Detection of phosphorylation of CaMKK targets in rat
brain extracts
Finally, we attempted to detect the phosphorylated sub-
strates of CaMKK within tissue extracts that were incu-
bated with recombinant CaMKKs in the presence of
Mg-GTP. When we used rat brain extracts, the phos-
phorylation of CaMKI at the activation Thr residue
(Thr177 in CaMKIα isoform) was enhanced by incuba-
tion of both CaMKK isoforms, and this phosphorylation
























































Figure 1 CaMKK can utilize various nucleotides as phosphate donors in vitro. A. Purified recombinant CaMKKα was incubated with
GST-CaMKIα (1-293, K49E, 0.5 mg/ml) at 30°C for 10 min in the solution containing 50 mM HEPES (pH 7.5), 1 mM DTT, 1 mM CaCl2, 10 mM Mg
(CH3COO)2, and 10 μM CaM in the absence (-) or presence of either 1 mM ATP, UTP, CTP, or GTP. After terminating the reaction, samples were
subjected to western blot analysis with either anti-GST antibody (A, upper panel) or anti-phospho-CaMKI antibody (A, lower panel). Similar results
were obtained for at least three independent experiments. B. Purified recombinant CaMKKα (+) was incubated with GST-CaMKIα (1-293, K49E,
0.5 mg/ml) at 30°C for 10 min in a solution used in panel A with (+) or without (-) 10 mM Mg(CH3COO)2, in the absence (-) or presence (+) of
1 mM ATP or 1 mM GTP. The reaction mixtures were heated at 68°C for 10 min (heat inactivated +) or kept on ice (-) before initiating the
phosphorylation reaction. After each reaction was terminated, samples were subjected to western blot analysis with either anti-GST antibody
(B, upper panel) or anti-phospho-CaMKI antibody (B, lower panel).
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by STO-609 (Figure 4A). In this experiment, we used
100 μM of GTP that is relatively lower than Km value
for GTP (CaMKKα, 444 μM; CaMKKβ, 507 μM, Table 1)
in order to reduce the background phosphorylation.
These results indicated that CaMKK was capable of
using Mg-GTP as a phosphate donor to phosphorylate
the target substrate even in the crude tissue lysate. We
then used western blot analysis and an anti-phospho-
threonine antibody to examine the phosphorylation pro-
file of rat brain extract that was incubated with Mg-GTP
in the presence of either EGTA or the CaMKK activator,
Ca2+/CaM (Figure 4B). In this experiment, we didn’t add
recombinant CaMKKs into the rat brain extract to
minimize the kinase concentration in the phosphoryl-
ation reaction but the endogenous CaMKK activity
should be apparently enhanced by using a relatively high
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Figure 2 Time course of CaMKK-mediated phosphorylation with various nucleotides of GST-CaMKIα (1-293, K49E) or AMPKα. Purified
recombinant CaMKKα (left panels) or CaMKKβ (right panels) was incubated with either GST-CaMKIα (1-293, K49E, A) or AMPK (B) at 30°C for the
indicated time periods in a solution containing 50 mM HEPES (pH 7.5), 10 mM Mg(CH3COO)2, 1 mM DTT, 1 mM CaCl2, 10 μM CaM, in the
presence of either 1 mM ATP (○), 1 mM GTP (•) or 1 mM UTP (▴) as described in "Methods." After each reaction was terminated, samples were
subjected to western blot analysis with either anti-phospho-CaMKI antibody (A, upper images) or anti-phospho-AMPKα antibody (B, upper images)
followed by quantitating the immunoreactive bands by densitometric scanning of the scientific imaging film used for detection of
chemiluminescence. Phosphate incorporation into each CaMKK target is expressed as a percentage of the value of the reaction for the 5-min
time point (30-min time point for AMPK) in the presence of ATP. Results are representative of at least two independent experiments.
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concentration of GTP (1mM) as compared to the Km
values for GTP. Although a number of proteins in brain
extracts had already been phosphorylated at Thr resi-
dues, we detected endogenous rat brain proteins with
molecular weight of ~60 kDa, ~45 kDa and ~35 kDa
(Figure 4B, indicated by an asterisk and arrow heads)
that exhibited increased phosphorylation levels following
the addition of Ca2+/CaM. However, phosphorylation of
a ~60 kDa protein was not suppressed by even high con-
centration (10 μg/ml) of STO-609; this finding suggested
that the 60 kDa phosphoprotein was not being phos-
phorylated by CaMKK. In addition, induced phosphoryl-
ation of the 45 kDa protein by GTP was observed in the
absence of Ca2+/CaM. This is probably due to phos-
phorylation by CaMKKβ whose kinase activity is highly
Ca2+/CaM-independent [30]. The phosphorylation levels of
a ~45 kDa and a ~35 kDa protein were significantly
reduced by addition of STO-609, indicating that these phos-
phoproteins might be substrates of CaMKK (Figure 4B).
It is noteworthy that we couldn’t clearly detect the
phospho-45 kDa and -35 kDa proteins when we used Mg-
ATP as a phosphate donor because of enhanced back-
ground phosphorylation (data not shown).
Conclusions
Searching for target substrates is always important to
evaluate the physiological significance of a protein kinase.
Since 1995, when CaMKK was cloned as an activator for
CaMKI and CaMKIV [10], we have attempted to develop
methods using enzyme-substrate interactions and an
ATP-analogue to search for novel CaMKK targets; in that
time, we found two potential CaMKK targets — SAD-B
[9] and Syndapin 1 [31]. Here, we attempted to examine
various nucleotides as phosphate donors for in vitro phos-
phorylation of target substrates by CaMKKs. We have
shown that CaMKK isoforms were capable of using Mg-
GTP as a phosphate donor. Usage of this nucleotide for
CaMKK activity varies depending on downstream targets.
1) Both CaMKK isoforms were capable of phosphorylating
CaMKIα (at Thr177) with Mg-GTP, as well as with Mg-
ATP. 2) AMPKα can be phosphorylated (at Thr172) with
Mg-GTP only by CaMKKβ, not by CaMKKα. Although
very few protein kinases are known to use GTP as well as
ATP, CaMKK is not the first protein kinase to use both
nucleotides. Casein kinase II has been well characterized
in its ability to use GTP and ATP [26,28,32]. Very recently,
Drosophila and rat CaMKIIα have been shown to utilize
GTP for exogenous substrate phosphorylation and autop-
hosphorylation in vitro [25]. In addition, previous reports
Table 1 Kinetic Parameters of CaMKK Isoforms
CaMKK Phosphate Km Vmax Vmax / Km
isoforms Donor (μM) (nmol/min/mg)
CaMKKα ATP 15 625 41.7
GTP 444 312 0.7
CaMKKβ ATP 15 286 19.1
GTP 507 77 0.2
CaMKK activities were measured using GST-CaMKIα (1-293, K49E) as a
substrate at 30°C in the presence of one of several concentrations
(50 – 400 μM) of either ATP or GTP as described in “Methods”.
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Figure 3 Effect of STO-609 on the activities of CaMKK isoforms with Mg-GTP. A. Recombinant CaMKKα (•) or recombinant CaMKKβ (○)
was incubated with GST-CaMKIα (1-293, K49E, 0.5 mg/ml) at 30°C for 4 min in the presence of 50 μM [γ-32P]GTP and 2 mM CaCl2/4 μM CaM with
various concentrations of STO-609 (0 – 10 μg/ml) as described in "Methods." Activities are expressed as a percentage of the value in the absence
of STO-609. Results represent mean and S.E. of three experiments. B. Protein kinase activities of purified recombinant CaMKKα (B, left panel) and
β (B, right panel) were measured with various concentrations (100 – 400 μM) of [γ-32P]GTP in either the absence (○) or presence (•) of 0.1 μg/ml
STO-609 for CaMKKα and in either the absence (○) or presence (•) of 0.01 μg/ml STO-609 for CaMKKβ. The results represent duplicate
experiments and are presented as double reciprocal plots (Lineweaver-Burk).
Yurimoto et al. BMC Biochemistry 2012, 13:27 Page 5 of 8
http://www.biomedcentral.com/1471-2091/13/27
have shown that four mammalian serine/threonine protein
kinases — including protein kinase Cδ, Nercc1, mst-3 and
AGT (O6-alkylguanine-DNA alkyltransferase) kinase —
are able to use GTP as a substrate [27,33-35]. However,
the physiological significance of GTP-dependent phos-
phorylation has been unexplored because ATP has been
recognized as the only biologically relevant phosphate
donor for protein kinases. In vitro, we found that the
phosphorylation of a CaMKK target protein, specifically
CaMKI, was induced by incubation of rat brain extract
with recombinant CaMKKs in the presence of Mg-GTP
and Ca2+/CaM, and that this phosphorylation was inhib-
ited by STO-609, a CaMKK inhibitor. Based on these
results, we suggest that this enzymatic feature of CaMKKs,
specifically the ability to use GTP or UTP in place of ATP
as phosphate donors in vitro, might be useful in screens
for novel CaMKK targets. However, careful consideration
should be required to use Mg-GTP as a phosphate donor
for CaMKK isoforms, since the differential effect of Mg-
GTP on the activities of CaMKK isoforms (Figure 2B).
Furthermore, the specificity of the CaMKK-mediated
phosphorylation reaction could be confirmed by addition
of the CaMKK inhibitor, STO-609, even though some en-
dogenous protein kinases have been shown to be capable
of using GTP as a phosphate donor in vitro. Indeed, we
detected two potential CaMKK target proteins with mo-
lecular weight of ~45 kDa and ~35 kDa whose phosphor-
ylation was induced by incubation of rat brain extract with
Mg-GTP and Ca2+/CaM and was inhibited by STO-609.
Based on the molecular weight of those phosphoproteins
on SDS-PAGE, ~35 kDa phosphoprotein might be a
member of CaMKI isoforms (Figure 4A). However, among
various known CaMKK target kinases including CaMKI,
CaMKIV, PKB, AMPK, and SAD-B [1-9], CaMKK target
with a molecular weight of ~45 kDa on SDS-PAGE has
not been identified. Further study to identify these putative
CaMKK substrates is absolutely required to evaluate novel
CaMKK-mediated signaling pathway. According to our
study, in vitro phosphorylation assays using GTP in com-
bination with STO-609 are expected to be a useful method
for detecting CaMKK substrates and assessing its function
(s) in various tissue and cells.
Methods
Materials
Recombinant CaMKKα and β were expressed in and puri-
fied from Escherichia coli as described previously [30].
Recombinant rat CaM was expressed in E. coli strain BL-
21 (DE3) using the pET-CaM plasmid (kindly provided by
Dr. Nobuhiro Hayashi, Fujita Health University, Toyoake,
Japan) and then purified by phenyl-Sepharose column
chromatography [36]. Mutant recombinant rat CaMKIα
(1-293, K49E) was expressed in E. coli strain JM-109 as a
GST-fusion protein and purified by glutathione Sepharose
column chromatography [15]. Recombinant AMPK was
expressed in E. coli strain BL21-CodonPlus (DE3) (Stratagene,
La Jolla, CA) using the tricistronic pγ1β1His-α1 plasmid



























































Figure 4 In vitro phosphorylation of CaMKK substrates in rat brain extract with Mg-GTP. A. Rat brain extract (5.6 mg/ml) was incubated
without (-) or with recombinant CaMKKα (α) or β (β) isoform (2 μg) in the absence (-) or presence (+) of 0.1 mM GTP at 30°C for 1 min in a
solution containing 50 mM HEPES (pH 7.5), 10 mM Mg(CH3COO)2, 2 mM DTT, 2 mM CaCl2 and 4.5 μM CaM and indicated concentrations
(0, 1, and 10 μg/ml) of STO-609, followed by western blot analysis with anti-phospho-CaMKI antibody. B. Rat brain extract (6.6 mg/ml) was
incubated without (-) or with 1 mM GTP (+) at 30°C for 30 min in the presence of either 2 mM EGTA (-) or 2 mM CaCl2/11 μM CaM (+) in a
solution containing 50 mM HEPES (pH 7.5), 10 mM Mg(CH3COO)2, 2 mM DTT and indicated concentrations (0, 1, or 10 μg/ml) of STO-609,
followed by western blot analysis with anti-phospho-threonine antibody. The asterisk and arrowheads indicate rat brain proteins whose
phosphorylation was induced by Ca2+/CaM. Results are representative of at least three independent experiments.
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Institute of Technology, Zurich, Switzerland) and purified
by Ni-NTA agarose column chromatography (Qiagen,
Hilden, Germany) [37]. Rabbit IgG antibodies against
AMPKα and those against phospho-AMPKα at Thr172
were purchased from Cell Signaling Technology, Inc.
(Danvers, MA). An anti-CaMKI antibody was purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). An
anti-GST antibody and an anti-phospho-threonine antibody
were purchased from GE Healthcare UK Ltd. (Bucking-
hamshire, UK) and from Invitrogen (Carlsbad, CA), re-
spectively. An anti-phospho-CaMKI (phospho-Thr177)
monoclonal antibody was generated as described previously
[38]. STO-609 was synthesized as described previously [29].
ATP, GTP, UTP and CTP were purchased from Roche Ap-
plied Science (Indianapolis, IN).
In vitro assay for CaMKK activity
Purified recombinant CaMKKs (CaMKKα, 0.9 μg/ml;
CaMKKβ, 1.7 μg/ml) were incubated individually with
GST-CaMKIα (1-293, K49E, 0.5 mg/ml) or AMPK (0.5
mg/ml) at 30°C for one of several defined time periods
in a solution containing 50 mM HEPES (pH 7.5), 10
mM Mg(CH3COO)2, 1 mM DTT, 1 mM CaCl2 (2 mM
in Figure 3), and 10 μM CaM (4 μM in Figure 3) in the
presence of either 1 mM nucleotide or one of several
defined concentrations between 50 and 400 μM of
either [γ-32P]ATP (1,200 – 10,000 cpm/pmol) or [γ-32P]
GTP (800 – 7,000 cpm/pmol); one of several defined
concentrations of STO-609 (0-10 μg/ml in dimethyl
sulfoxide at a final concentration of 4%) was included in
individual reactions. Each reaction was initiated by the
addition of cold nucleotide or [γ-32P]ATP or [γ-32P]
GTP and terminated by addition of an equal volume of
2 x SDS-PAGE sample buffer; each terminated reaction
was then subjected to SDS-PAGE or to spotting of ali-
quots (20 μl) onto phosphocellulose paper (Whatman
P-81). These spotted phosphocellulose papers were then
washed several times with 75 mM phosphoric acid.
Phosphate incorporation into GST-CaMKIα (1-293,
K49E) was determined using western blots generated
with the gels and an anti-phospho-CaMKI antibody or
using the spotted filters that were subjected to liquid
scintillation counts.
Phosphorylation within rat brain extract
Rat brain samples were homogenized with 5 volumes of
homogenization buffer (150 mM NaCl, 50 mM Tris-HCl
(pH 7.5), 1 mM DTT, 1 mM EGTA, 1 mM EDTA, 0.2
mM phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin,
10 μg/ml trypsin inhibitor, 1% NP-40); homogenates
were then centrifuged at 30,190 x g at 4°C for 30 min.
The supernatant was stored at -80°C until use. Rat brain
extract was incubated in a solution (100 μl) containing
50 mM HEPES (pH 7.5), 10 mM Mg(CH3COO)2, 2 mM
DTT, 2 mM CaCl2, and CaM, 0.5 μM okadaic acid; each
sample was incubated in the absence or presence of either
0.1 mM or 1 mM GTP at 30°C for 1 or 30 min with or
without recombinant CaMKKs for indicated time periods.
Each reaction was terminated by addition of 20 μl of SDS-
PAGE sample buffer followed by western blot analysis
with either anti-phospho-CaMKI antibody and anti-
CaMKI antibody or anti-phospho-threonine antibody.
Others
Staining of western blots was performed with horseradish
peroxidase-conjugated anti-mouse IgG, anti-rabbit IgG
(GE Healthcare UK Ltd., Buckinghamshire, UK), or anti-
goat IgG antibody (Sigma, Saint Louis, MO) as a secondary
antibody and chemiluminescence reagent (PerkinElmer
Life Sciences, Waltham, MA) for signal detection. The in-
tensity of the immunoreactive band was measured by
densitometric scanning of scientific imaging film (KODAK
BioMax Light Film, Carestream Health, Inc., Rochester,
NY) for detection and measurement of chemilumi-
nescence. Bradford reagent (Bio-Rad Laboratories, Inc.,
Hercules, CA) was used to estimate protein concentration;
bovine serum albumin was used as the protein standard.
Abbreviations
CaM: Calmodulin; CaMK: Ca2+/CaM-dependent protein kinase; CaMKK:
Ca2+/CaM-dependent protein kinase kinase; AMPK: 50AMP-activated protein
kinase; STO-609: 7H-benzimidazo[2,1-a]benz[de]isoquinoline-7-one-3-
carboxylic acid; GST: Glutathione S-transferase; DTT: Dithiothreitol.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SY participated in the experimental design, performance of research, data
analysis and writing of the paper. TF originally started this work and
participated in the kinetic analysis of CaMKKs. MM and NK participated in
study design and took part in manuscript writing. RK supervised the work.
HT is the principle investigator of this project and participated in research
design, data analysis and writing of paper. All authors read and approved
the final manuscript.
Acknowledgment
We thank Momoko Nitta (Kagawa University) for excellent technical
assistance. Saki Yurimoto is a Research Fellow of Japan Society for the
Promotion of Science (22-1342).
Received: 25 September 2012 Accepted: 29 November 2012
Published: 5 December 2012
References
1. Hook SS, Means AR: Ca2+/CaM-dependent kinases: from activation to
function. Annu Rev Pharmacol Toxicol 2001, 41:471–505.
2. Means AR: The year in basic science: calmodulin kinase cascades.
Mol Endocrinol 2008, 22:2759–2765.
3. Soderling TR: The Ca-calmodulin-dependent protein kinase cascade.
Trends Biochem Sci 1999, 24:232–236.
4. Yano S, Tokumitsu H, Soderling TR: Calcium promotes cell survival
through CaM-K kinase activation of the protein-kinase-B pathway.
Nature 1998, 396:584–587.
5. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR,
Carlson M, Carling D: Ca2+/calmodulin-dependent protein kinase kinase-
beta acts upstream of AMP-activated protein kinase in mammalian cells.
Cell Metab 2005, 2:21–33.
Yurimoto et al. BMC Biochemistry 2012, 13:27 Page 7 of 8
http://www.biomedcentral.com/1471-2091/13/27
6. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA: The
Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated
protein kinase kinases. J Biol Chem 2005, 280:29060–29066.
7. Hong SP, Momcilovic M, Carlson M: Function of mammalian LKB1 and
Ca2+/calmodulin-dependent protein kinase kinase alpha as Snf1-
activating kinases in yeast. J Biol Chem 2005, 280:21804–21809.
8. Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG:
50-AMP activates the AMP-activated protein kinase cascade, and
Ca2+/calmodulin activates the calmodulin-dependent protein kinase
I cascade, via three independent mechanisms. J Biol Chem 1995,
270:27186–27191.
9. Fujimoto T, Yurimoto S, Hatano N, Nozaki N, Sueyoshi N, Kameshita I,
Mizutani A, Mikoshiba K, Kobayashi R, Tokumitsu H: Activation of SAD
kinase by Ca2+/calmodulin-dependent protein kinase kinase. Biochemistry
2008, 47:4151–4159.
10. Tokumitsu H, Enslen H, Soderling TR: Characterization of a
Ca2+/calmodulin-dependent protein kinase cascade. Molecular cloning
and expression of calcium/calmodulin-dependent protein kinase kinase.
J Biol Chem 1995, 270:19320–19324.
11. Kimura Y, Corcoran EE, Eto K, Gengyo-Ando K, Muramatsu MA, Kobayashi R,
Freedman JH, Mitani S, Hagiwara M, Means AR, et al: A CaMK cascade
activates CRE-mediated transcription in neurons of Caenorhabditis
elegans. EMBO Rep 2002, 3:962–966.
12. Joseph JD, Means AR: Identification and characterization of two
Ca2+/CaM-dependent protein kinases required for normal nuclear
division in Aspergillus nidulans. J Biol Chem 2000, 275:38230–38238.
13. Anderson KA, Means RL, Huang QH, Kemp BE, Goldstein EG, Selbert MA,
Edelman AM, Fremeau RT, Means AR: Components of a calmodulin-
dependent protein kinase cascade. Molecular cloning, functional
characterization and cellular localization of Ca2+/calmodulin-dependent
protein kinase kinase beta. J Biol Chem 1998, 273:31880–31889.
14. Tokumitsu H, Soderling TR: Requirements for calcium and calmodulin in
the calmodulin kinase activation cascade. J Biol Chem 1996,
271:5617–5622.
15. Tokumitsu H, Muramatsu M, Ikura M, Kobayashi R: Regulatory mechanism
of Ca2+/calmodulin-dependent protein kinase kinase. J Biol Chem 2000,
275:20090–20095.
16. Osawa M, Tokumitsu H, Swindells MB, Kurihara H, Orita M, Shibanuma T,
Furuya T, Ikura M: A novel target recognition revealed by calmodulin in
complex with Ca2+-calmodulin-dependent kinase kinase. Nat Struct Biol
1999, 6:819–824.
17. Sheng M, Thompson MA, Greenberg ME: CREB: a Ca2+-regulated
transcription factor phosphorylated by calmodulin-dependent kinases.
Science 1991, 252:1427–1430.
18. Ribar TJ, Rodriguiz RM, Khiroug L, Wetsel WC, Augustine GJ, Means AR:
Cerebellar defects in Ca2+/calmodulin kinase IV-deficient mice. J Neurosci
2000, 20:RC107.
19. Wu JY, Ribar TJ, Cummings DE, Burton KA, McKnight GS, Means AR:
Spermiogenesis and exchange of basic nuclear proteins are impaired in
male germ cells lacking Camk4. Nat Genet 2000, 25:448–452.
20. Saneyoshi T, Wayman G, Fortin D, Davare M, Hoshi N, Nozaki N, Natsume T,
Soderling TR: Activity-dependent synaptogenesis: regulation by a CaM-
kinase kinase/CaM-kinase I/betaPIX signaling complex. Neuron 2008,
57:94–107.
21. Wayman GA, Impey S, Marks D, Saneyoshi T, Grant WF, Derkach V, Soderling
TR: Activity-dependent dendritic arborization mediated by CaM-kinase I
activation and enhanced CREB-dependent transcription of Wnt-2. Neuron
2006, 50:897–909.
22. Ageta-Ishihara N, Takemoto-Kimura S, Nonaka M, Adachi-Morishima A,
Suzuki K, Kamijo S, Fujii H, Mano T, Blaeser F, Chatila TA, et al: Control of
cortical axon elongation by a GABA-driven Ca2+/calmodulin-dependent
protein kinase cascade. J Neurosci 2009, 29:13720–13729.
23. Tamas P, Hawley SA, Clarke RG, Mustard KJ, Green K, Hardie DG, Cantrell DA:
Regulation of the energy sensor AMP-activated protein kinase by
antigen receptor and Ca2+ in T lymphocytes. J Exp Med 2006,
203:1665–1670.
24. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG,
Hardie DG: Calmodulin-dependent protein kinase kinase-beta is an
alternative upstream kinase for AMP-activated protein kinase. Cell Metab
2005, 2:9–19.
25. Bostrom SL, Dore J, Griffith LC: CaMKII uses GTP as a phosphate donor for
both substrate and autophosphorylation. Biochem Biophys Res Commun
2009, 390:1154–1159.
26. Gatica M, Hinrichs MV, Jedlicki A, Allende CC, Allende JE: Effect of metal
ions on the activity of casein kinase II from Xenopus laevis. FEBS Lett
1993, 315:173–177.
27. Gschwendt M, Kittstein W, Kielbassa K, Marks F: Protein kinase C delta
accepts GTP for autophosphorylation. Biochem Biophys Res Commun 1995,
206:614–620.
28. Niefind K, Putter M, Guerra B, Issinger OG, Schomburg D: GTP plus water
mimic ATP in the active site of protein kinase CK2. Nat Struct Biol 1999,
6:1100–1103.
29. Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R: STO-609,
a specific inhibitor of the Ca2+/calmodulin-dependent protein kinase
kinase. J Biol Chem 2002, 277:15813–15818.
30. Tokumitsu H, Iwabu M, Ishikawa Y, Kobayashi R: Differential regulatory
mechanism of Ca2+/calmodulin-dependent protein kinase kinase
isoforms. Biochemistry 2001, 40:13925–13932.
31. Fujimoto T, Hatano N, Nozaki N, Yurimoto S, Kobayashi R, Tokumitsu H:
Identification of a novel CaMKK substrate. Biochem Biophys Res Commun
2011, 410:45–51.
32. Rodnight R, Lavin BE: Phosvitin kinase from brain: activation by ions and
subcellular distribution. Biochem J 1964, 93:84–91.
33. Mullapudi SR, Ali-Osman F, Shou J, Srivenugopal KS: DNA repair protein
O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct
and novel protein kinases in human brain tumour cells. Biochem J 2000,
351(Pt 2):393–402.
34. Roig J, Mikhailov A, Belham C, Avruch J: Nercc1, a mammalian NIMA-
family kinase, binds the Ran GTPase and regulates mitotic progression.
Genes Dev 2002, 16:1640–1658.
35. Schinkmann K, Blenis J: Cloning and characterization of a human STE20-
like protein kinase with unusual cofactor requirements. J Biol Chem 1997,
272:28695–28703.
36. Hayashi N, Matsubara M, Takasaki A, Titani K, Taniguchi H: An expression
system of rat calmodulin using T7 phage promoter in Escherichia coli.
Protein Expr Purif 1998, 12:25–28.
37. Neumann D, Woods A, Carling D, Wallimann T, Schlattner U: Mammalian
AMP-activated protein kinase: functional, heterotrimeric complexes by
co-expression of subunits in Escherichia coli. Protein Expr Purif 2003,
30:230–237.
38. Tokumitsu H, Hatano N, Inuzuka H, Yokokura S, Nozaki N, Kobayashi R:
Mechanism of the generation of autonomous activity of
Ca2+/calmodulin-dependent protein kinase IV. J Biol Chem 2004,
279:40296–40302.
doi:10.1186/1471-2091-13-27
Cite this article as: Yurimoto et al.: In vitro substrate phosphorylation by
Ca2+/calmodulin-dependent protein kinase kinase using guanosine-50-
triphosphate as a phosphate donor. BMC Biochemistry 2012 13:27.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yurimoto et al. BMC Biochemistry 2012, 13:27 Page 8 of 8
http://www.biomedcentral.com/1471-2091/13/27
